Dr Reddy's Laboratories shed around 7% as USFDA issues 3 obs

Shares of Dr Reddy's Laboratories (DRL) shed almost 7 percent in trade on Monday after the US Food and Drug Administration (USFDA) issued three observations for the company's Telangana plant.

Related Keywords

India , Reddy Bachupally , Board Of Directors The Company , Stock Options , Employees Stock Option Scheme , Option Scheme , Dr Reddys Laboratories , Dr Reddys Laboratories Stock , Dr Reddys Laboratories Share , Dr Reddys Laboratories Share Price , Dr Reddys Laboratories Observations , Usfda , Markets , Stocks , Stock Markets , Pharma , Pharma Sector , Pharma Stocks , Trending , Dr Reddys Laboratories News , Dr Reddy S , Dr Reddys News , Market News ,